In a November 26, 2018 order, the U.S. District Court for the
District of Delaware ordered the Wisconsin Alumni Research Fund
(WARF) to pay The Washington University – St. Louis
(Wash. U.) $31.6 million for breach of contract (The Washington
University v. Wisconsin Alumni Research Foundation, Civ. No.
13-2091-JFB). The case originated when Wash. U. filed suit
against WARF for breach of contract, breach of fiduciary duty,
breach of the implied covenant of good faith and fair dealing, and
equitable accounting, relating to a 1995 agreement between the
parties entitled "Inter-Institutional Agreement for Prevention
of Hyperphosphatemia in Kidney Disorder Patients" (the
"IIA"), and particularly relating to the drug
paracalcitol. The IIA covered certain patent rights for US
Patent 5,597,815, jointly owned by Wash. U. and WARF. In the
IIA, Wash. U. granted to WARF "the exclusive right to
negotiate, execute, administer, and enforce License Agreement(s),
and WARF shall have